Providing market research reports, industry analysis, company profiles and country reports for strategic planning, competitive intelligence, marketing and business research.
Search for Market Research Reports:    

Avigen Inc: Premium Company Profile

Published by: Datamonitor

Published: Apr. 22, 2008 - 39 Pages


Table of Contents


Overview
Catalyst
Summary
Company Structure
Company Overview and Key Facts
Business Description
History
Company Financials
Stock Market Performance
P&L
Balance Sheet
Cash Flow
Products & Services
Pipeline Products
Competitors and Strategic Business Relationships
Key Competitors
Key Suppliers
Key Clients
Shareholding Structure
Strategy
Company View
Corporate Strategy
SWOT Analysis
Overview
Strengths
Weaknesses
Opportunities
Threats
Value Chain Analysis
Overview
Discovery and Product Development
Key Employees
List of Employees
Key Employee Biographies
Financial and Operational Overview
Financial and Operational Overview
APPENDIX
Ask the analyst
Datamonitor consulting
Disclaimer
TABLE OF FIGURES
Figure 1: Avigen - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn)
TABLE OF TABLES
Table 1: Avigen - Key Facts
Table 2: Avigen - Year-End Share Price and Market Capitalization, 2002-2006 ($)
Table 3: Avigen - Key Events Impacting Share Price Performance
Table 4: Avigen - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn)
Table 5: Avigen - Operating Cost Ratio Analysis, 2002-2006 (% of total revenues)
Table 6: Avigen - Balance Sheet
Table 7: Avigen - Cash Flow
Table 8: Avigen - In-house Pipeline Products
Table 9: Avigen - Key Competitors
Table 10: Avigen - Key Suppliers
Table 11: Avigen - Key Clients
Table 12: Avigen - Key Shareholders
Table 13: Avigen - SWOT Analysis Summary
Table 14: Avigen - Value Chain Analysis
Table 15: Avigen - Key Employees
Table 16: Avigen- Financial and Operational Overview


Abstract

Introduction

Avigen is a development stage biopharmaceutical company focusing on small molecule therapeutics and biologics to treat neurological and neuromuscular disorders. The company’s current pipeline products primarily address spasticity and neuromuscular spasm and neuropathic pain.

Scope

Contains corporate strategy, value chain presence and SWOT Analysis Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors Includes information on suppliers/ partners, shareholding structure and key employees with biographies

Highlights

Avigen’s development programs include AV650 in Phase II trials for spasticity and neuromuscular spasm; AV411 in Phase I trials and AV333 in preclinical for neuropathic pain. Further, in collaboration with University of Colorado Avigen explores the use of AV411 for opioid withdrawal. The company’s revenues increased at a CAGR of 16% during 2002-2006 from $0.057 million to $0.103 million. The increase in revenues was primarily due to the deferred revenues from Bayer in connection with the development of Coagulin-B for the treatment of hemophilia-B. In addition, Avigen received license fee and royalty payments on adeno-associated virus (AAV) technology; and grants from National Institutes of Health (NIH) for exploring the use of AV411 for neuropathic pain, in collaboration with University of Colorado.

Reasons to Purchase

Access all the important information and analysis on the company in a single report Understand company’s strengths, weaknesses, opportunities and threats along with business strategy and value chain Gain access to company’s adjusted five year financial data along with key ratios and market capitalization .

Please note: This is delivered as a Zip file.


Get Full Details About This Report >>
US: 800.298.5699
Int'l: +1.240.747.3093
Buy this Report
Price and Delivery Options
Search Inside Report


 

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.

 

© MarketResearch.com 2008